Clarius Group, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$7,291,000
+29.7%
109,2300.0%3.07%
+32.6%
Q2 2017$5,620,000
-11.9%
109,2300.0%2.32%
-12.1%
Q1 2017$6,379,000
+40.0%
109,2300.0%2.63%
+36.6%
Q4 2016$4,558,000
-21.0%
109,2300.0%1.93%
-28.3%
Q3 2016$5,770,000
+188.9%
109,230
+129.2%
2.69%
+152.8%
Q2 2016$1,997,000
+3.2%
47,6660.0%1.06%
-0.8%
Q1 2016$1,935,00047,6661.07%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders